Skip to main content
. Author manuscript; available in PMC: 2013 Apr 12.
Published in final edited form as: Am J Obstet Gynecol. 2008 May;198(5):577.e1–577.e5. doi: 10.1016/j.ajog.2007.12.033

Table I.

Patient Characteristics

Quit Use
N=30
Continued Use
N=34
P

Age ± SD (yrs) 50.5 ± 10.9 53.5 ± 12.1 0.30*

Mean BMI± SD (kg/cm2) 30.3 ± 6.8 27.3 ± 5.3 0.07*

Parity (mean) [rank score] Mean=2.8 [score=34.6] Mean=2.4 [score=30.7] 0.39

Ethnicity (%): 0.56
 Caucasian 18 (60) 24 (72)
 Hispanic 9 (30) 7 (21)
 Other 3 (10) 2 (6)

Postmenopausal (%) 15 (50) 16 (47) 1.0
Hormone treatment 5 (16) 3 (8) 0.46

Sexually Active (%) 17 (57) 21 (62) 0.6

POP-Q Stage by compartment Mean stage [rank score]
 Anterior Mean=1.8 [score=28.7] Mean=2.1 [score=34.7] 0.17
 Apex Mean=1.2 [score=29.6] Mean=1.2 [score=31.4] .64
 Posterior Mean=1.1 [score=27.5] Mean=1.5 [score=34.2] 0.12
 Overall POP-Q Mean=1.9 [score=28.9] Mean= 2.1 [score=34.6] 0.18
*

2 sample T-test (Satterthwaite unpaired t-test)

Wilcoxon Rank Sum Test

Fishers exact test